Capra Biosciences
Biotechnology ResearchVirginia, United States11-50 Employees
Capra Biosciences is a biotechnology research company developing a bioreactor approach intended to lower end-to-end manufacturing costs for chemicals produced via biology. It aims to make biobased chemicals competitive with petroleum-based products by addressing scale-up bottlenecks in production. Based in Sterling, Virginia, the company engages with academic and research partners to advance its technology, including collaborations with Boston University, Virginia Tech, Syracuse University, ATCC, and Next Rung Technology, often in a primary-contractor role. In May 2026, Capra announced the launch of a naturally derived salicylic acid for personal care applications at NYSCC Suppliers' Day. The firm operates within the biotechnology research space focused on sustainable domestic production of high-value chemicals and pursues partnerships to validate and refine its processes, including efforts around opportunistic consumption by switching between feedstocks.